Refractory diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor use

被引：0
作者：
Ravishankar, Nivedha [1 ]
Clayton, Samantha [1 ]
机构：
[1] West Suffolk Hosp, Bury St Edmunds, Suffolk, England
来源：
ANAESTHESIA | 2024年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
016
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
[21]   Sodium-Glucose Co-transporter 2 Inhibitor: The Magic Bullet for Obesity in Diabetes? [J].
Seo, Ji A. .
JOURNAL OF OBESITY & METABOLIC SYNDROME, 2018, 27 (01) :1-3
[22]   Safety of Sodium-Glucose Co-Transporter 2 Inhibitors [J].
McGill, Janet B. ;
Subramanian, Savitha .
AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 :S45-S52
[23]   Safety of Sodium-Glucose Co-Transporter 2 Inhibitors [J].
McGil, Janet B. ;
Subramanian, Savitha .
AMERICAN JOURNAL OF MEDICINE, 2019, 132 (10) :S49-+
[24]   Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes. Part B: Risks of sodium-glucose co-transporter inhibitor use in type 1 diabetes and ketoacidosis risk mitigation strategies [J].
Ngan, Jennifer ;
O'Neal, David N. ;
Lee, Melissa H. ;
Kong, Yee Wen ;
MacIsaac, Richard J. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 226
[25]   Sodium-glucose co-transporter 2 inhibitors and hematopoiesis [J].
Yaribeygi, Habib ;
Maleki, Mina ;
Nasimi, Fatemeh ;
Butler, Alexandra E. ;
Jamialahmadi, Tannaz ;
Sahebkar, Amirhossein .
JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (10) :3778-3787
[26]   CONSIDERATIONS FOR SODIUM-GLUCOSE TRANSPORTER 2 INHIBITOR THERAPY RESULTING IN EUGLYCEMIC DIABETIC KETOACIDOSIS [J].
Patel, Parth ;
Patel, Tarang ;
Patil, Sachin ;
Patel, Shaili ;
Ang, Jonathan Ross .
CHEST, 2021, 160 (04) :981A-982A
[27]   Sodium-Glucose Co-Transporter 2 Inhibitor-induced Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetes Patient Not Absolutely Insulin-deficient! [J].
Mukthar, Mamoun ;
Skaria, Sijomol ;
Ahmed, Ramadan Abdelsalam Beshir ;
Elmalti, Akrem Y. M. .
IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2019, 11 (01) :35-37
[28]   Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction [J].
Tiwary, Mansi ;
Milder, Tamara Y. ;
Stocker, Sophie L. ;
Day, Richard O. ;
Greenfield, Jerry R. .
INTERNAL MEDICINE JOURNAL, 2022, 52 (10) :1666-1676
[29]   Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects [J].
Norton, Luke ;
Shannon, Christopher E. ;
Fourcaudot, Marcel ;
Hu, Cheng ;
Wang, Niansong ;
Ren, Wei ;
Song, Jun ;
Abdul-Ghani, Muhammad ;
DeFronzo, Ralph A. ;
Ren, Jimmy ;
Jia, Weiping .
DIABETES OBESITY & METABOLISM, 2017, 19 (09) :1322-1326
[30]   Acute interstitial nephritis due to sodium-glucose co-transporter 2 inhibitor empagliflozin [J].
Ryan, Rebecca ;
Choo, Stephanie ;
Willows, Jamie ;
Walker, Julie ;
Prasad, Kolanu ;
Tez, Didem .
CLINICAL KIDNEY JOURNAL, 2021, 14 (03) :1020-1022
12345